About Resolve

At Resolve we have one mission: save lives. We will save 100 million lives by implementing proven solutions to prevent heart disease and stroke, the world’s leading cause of death. And we are helping the world prevent the next disease outbreak by catalyzing country action to find, stop and prevent new disease threats.     

With $225 million dollars from Bloomberg Philanthropies, the Chan Zuckerberg Initiative, and the Bill & Melinda Gates Foundation, Resolve uses proven strategies to take urgent action that improves health in low- and middle-income countries.

Our team of global health experts works with governments to help them implement evidence-based strategies that allow their citizens to lead the healthiest lives possible. The New York City-based initiative is led by Dr. Tom Frieden, former director of the Centers for Disease Control and Prevention, and is housed within Vital Strategies, a global health organization that works in 60 countries to address the world’s most challenging health issues.  Resolve fits perfectly with Vital Strategies’ vision of a world where every person is protected by a strong public health system.



About Dr. Tom Frieden

Dr. Tom Frieden is one of the world’s leading public health experts.  Dr. Frieden is President and Chief Executive Officer of Resolve, a $225 million, 5-year initiative housed at Vital Strategies, a non-profit global health organization working toward the vision that all people are protected by a strong public health system. The Resolve initiative aims to save millions of lives from cardiovascular disease and make the world safer from epidemics.  Resolve is funded by Bloomberg Philanthropies, the Chan Zuckerberg Initiative, and the Bill & Melinda Gates Foundation. 

Dr. Frieden was Director of the Centers for Disease Control and Prevention (CDC) from 2009 to 2017, and led the CDC work that helped end the Ebola epidemic.  Over the course of his career, he controlled the largest outbreak of multi-drug resistant tuberculosis ever to occur in the United States, helped establish the largest tuberculosis control program in the world in India, and directed efforts on several public health issues that led to a rapid increase in life expectancy in New York City. 

Because of his leadership at CDC, Americans are safer from antibiotic resistance, foodborne and healthcare-associated infections, heart attacks, strokes, cancer, and exposure to dangerous pathogens.  A physician trained in internal medicine, infectious diseases, public health, and epidemiology, Frieden has published cutting-edge, widely cited research on a broad range of topics.  He has transformed the organizations he has led, creating global models of scientific rigor, maximum accountability, measurable impact, community engagement and increased staff morale.

As New York City Health Commissioner from 2002-2009, Dr. Frieden led efforts to reduce smoking, eliminate artificial trans fats from restaurants, initiate the country’s largest community-based electronic health records project, and eliminate colon cancer screening disparities, among other critical initiatives.  During his time as Commissioner, life expectancy in New York City increased by three years, a faster increase than in the United States as a whole.

Dr. Frieden also designed and launched Bloomberg Philanthropies’ Initiative to Reduce Tobacco Use, a program that has so far supported policies which have saved 30 million lives, with much more life-saving potential ahead.

From 1992-1996, he led New York City’s tuberculosis control program that reduced multidrug-resistant cases by 80 percent.  Dr. Frieden then worked in India helping build a tuberculosis control program that has saved more than three million lives.

Dr. Frieden received medical and public health degrees from Columbia University, completed infectious disease Fellowship at Yale University, and was an Epidemic Intelligence Service Officer at CDC.  He is the author of over 200 scientific publications.

recent Publications

Saving an additional 100 million lives and Supplementary appendix
The Lancet
September 2017

Evidence for Health Decision Making - Beyond Randomized, Controlled
The New England Journals of Medicine
August 2017

A Safer, Healthier U.S.: The Centers for Disease Control and Prevention
American Journal of Preventive Medicine
March 2017

The Future of Public Health.
The New England Journals of Medicine
October 2015

Ebola in West Africa--CDC's Role in Epidemic Detection, Control, and Prevention.
Centers for Disease Control and Prevention
November 2015

A public health approach to global management of hypertension.
The Lancet
February 2015

Six components necessary for effective public health program implementation.
American Journal of Public Health
January 2014

The "Million Hearts" initiative--preventing heart attacks and strokes.
The New England Journals of Medicine
September 2015

Deaths preventable in the U.S. by improvements in use of clinical preventive services.
American Journal of Preventive Medicine
June 2010


Dr. Tom Frieden discusses Ebola treatment modeling.